Total Payments
$2,195
2024 Payments
$246.11
Companies
13
Transactions
77
Medicare Patients
144
Medicare Billing
$28,378
Payment Breakdown by Category
Food & Beverage$2,042 (93.1%)
Education$152.49 (6.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,042 | 74 | 93.1% |
| Education | $152.49 | 3 | 6.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $470.38 | 11 | $0 (2024) |
| ITI, Inc. | $439.33 | 14 | $0 (2023) |
| ABBVIE INC. | $293.78 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $203.50 | 6 | $0 (2023) |
| Axsome Therapeutics, Inc. | $161.68 | 4 | $0 (2024) |
| Indivior Inc. | $138.13 | 7 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $135.43 | 3 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $125.28 | 4 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $95.07 | 6 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $73.05 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $246.11 | 9 | Axsome Therapeutics, Inc. ($136.90) |
| 2023 | $681.82 | 15 | Alkermes, Inc. ($231.41) |
| 2022 | $660.98 | 35 | Indivior Inc. ($121.69) |
| 2021 | $605.68 | 18 | ITI, Inc. ($185.27) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Psychology/Psychiatric | ||||||
| 07/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: CNS | ||||||
| 04/22/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Central Nervous System | ||||||
| 01/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/26/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: PSYCHIATRY | ||||||
| 11/28/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: PSYCHIATRY | ||||||
| 11/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $111.53 | General |
| Category: CNS | ||||||
| 11/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $119.88 | General |
| Category: CNS | ||||||
| 08/23/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $129.30 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.86 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Neuroscience | ||||||
| 10/18/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $36.28 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 23 | 94 | $11,493 | $6,537 |
| 2022 | 1 | 21 | 81 | $9,904 | $5,098 |
| 2021 | 2 | 39 | 132 | $14,366 | $7,448 |
| 2020 | 2 | 61 | 188 | $21,095 | $9,294 |
Total Patients
144
Total Services
495
Medicare Billing
$28,378
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 94 | $11,493 | $6,537 | 56.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 81 | $9,904 | $5,098 | 51.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 87 | $10,637 | $5,563 | 52.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 45 | $3,728 | $1,886 | 50.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 140 | $17,118 | $7,626 | 44.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 48 | $3,977 | $1,668 | 41.9% |
About Michelle Ducat, APN
Michelle Ducat, APN is a Psychiatric/Mental Health, Adult healthcare provider based in Amelia, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2011. The National Provider Identifier (NPI) number assigned to this provider is 1013297811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Ducat, APN has received a total of $2,195 in payments from pharmaceutical and medical device companies, with $246.11 received in 2024. These payments were reported across 77 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,042).
As a Medicare-enrolled provider, Ducat has provided services to 144 Medicare beneficiaries, totaling 495 services with total Medicare billing of $28,378. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health, Adult
- Other Specialties Adult
- Location Amelia, OH
- Active Since 08/24/2011
- Last Updated 08/24/2011
- Taxonomy Code 364SP0809X
- Entity Type Individual
- NPI Number 1013297811
Products in Payments
- CAPLYTA (Drug) $462.33
- VRAYLAR (Drug) $293.78
- ARISTADA (Drug) $255.88
- LYBALVI (Drug) $214.50
- INVEGA SUSTENNA (Drug) $203.50
- Auvelity (Drug) $161.68
- PERSERIS (Drug) $138.13
- INGREZZA (Drug) $135.43
- LATUDA (Drug) $95.07
- ABILIFY MAINTENA (Drug) $80.15
- AUSTEDO (Drug) $53.05
- REXULTI (Drug) $45.13
- FANAPT (Drug) $22.27
- Austedo XR (Drug) $20.00
- TRINTELLIX (Drug) $13.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.